OR11H7

Across TCGA pan-cancer cohorts, OR11H7 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated OR11H7 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher OR11H7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR11H7 expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCS show a favorable association.

KIRP, COAD, and UVM are the cancer types where OR11H7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.786	0.940	<.001	86	view →
COAD	OS	Tertile	All	0.664	0.869	<.001	84	view →
UVM	DFS	Tertile	II,III,IV	0.319	0.764	.001	76	view →
BRCA	OS	Tertile	All	0.950	0.888	<.001	69	view →
KIRC	DFS	Tertile	II,III,IV	0.389	0.628	<.001	59	view →
UCS	OS	Quartile	II,III,IV	0.727	0.169	.002	56	view →
BLCA	DFS	Median	All	0.555	0.692	.002	42	view →
ACC	DFS	Median	All	0.452	0.758	.006	35	view →
LGG	OS	Median	All	0.864	0.927	.003	24	view →
CESC	OS	Median	All	0.858	0.735	.006	12	view →
STAD	DFS	Median	IV	0.211	0.599	.024	11	view →
HNSC	OS	Quartile	All	0.291	0.426	.018	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

OR11H7–KIRP (DFS)

Open the KIRP breakdown →